Upset fans were vocal in the comment section of a YouTube video in which Rohner, 37, said she had taken a GLP-1, calling into ...

Author of The Perimenopause Plan Faye James explains why microdosing a GLP-1 in perimenopause is not recommended.

Their own mini-boom of recent years has been largely fueled by one firm, Ozempic maker Novo Nordisk A/S, whose diabetes and ...

President Donald Trump is under pressure to decide how widely available anti-obesity drugs should be and whether Medicare should cover them.

Wellness influencer Janelle Rohner reveals she is 'microdosing' GLP-1 medication for weight loss and addresses criticism over ...

Cheung, one of Trump's closest allies, reffered to Coles as a "piece of sh*t" after she speculated the president might not be ...

Health and wellness influencer Janelle Rohner is receiving backlash after revealing that she’s been taking medication for ...

Eli Lilly announced clinical trial results this week for a daily pill to treat obesity and diabetes. Its name is absolutely ...

Runners, cyclists and other fitness enthusiasts say weight-loss drugs give them a performance edge, despite potential risks.

Studies in neuroscience with applications to humans offer clues about what makes us start eating, and when we stop.

Novo Nordisk remains financially strong, but pricing pressures and CagriSema challenges limit near-term upside. Find out why ...

Tess Holliday, model and body activist, responded to a critic who suggested she should take Ozempic. Ozempic is a medication ...